„First Line“

Suchergebnisse

3.416 Treffer

• Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
  Sanden, Suzy Van ; Baculea, Simona ; Diels, Joris ; Cote, Sarah
• Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy
  Kammerer-Jacquet, Solene-Florence ; Medane, Sarah ; Bensalah, Karim ; Bernhard, Jean-Christophe ; Yacoub, Mokrane ; Dupuis, Frantz ; Ravaud, Alain ; Verhoest, Grégory ; Mathieu, Romain ; Peyronnet, Benoit ; Brunot, Angélique ; Laguerre, Brigitte ; Lespagnol, Alexandra ; Mosser, Jean ; Dugay, Frédéric ; Belaud-Rotureau, Marc-Antoine ; Rioux-Leclercq, Nathalie
• Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry
  Kanda, Ryuichiro ; Miyazaki, Yusuke ; Nakayamada, Shingo ; Fukuyo, Shunsuke ; Kubo, Satoshi ; Miyagawa, Ippei ; Yamaguchi, Ayako ; Satoh-Kanda, Yurie ; Ohkubo, Naoaki ; Todoroki, Yasuyuki ; Tanaka, Hiroaki ; Ueno, Masanobu ; Nagayasu, Atsushi ; Fujita, Yuya ; Aritomi, Takafumi ; Kusaka, Katsuhide ; Sakai, Hidenori ; Matsunaga, Satsuki ; Nohara, Hirotsugu ; Tanaka, Yoshiya
• Students’ choice and perceived importance of resources in first-year university calculus and linear algebra
  Kock, Zeger-Jan ; Brunetto, Domenico ; Pepin, Birgit 2020 Universität Duisburg-Essen
• Efficacy and tolerability of vildagliptin as first line treatment in patients with diabetes type 2 in an outpatient setting
  Yavropoulou, M. P. ; Pikilidou, M. ; Kotsa, K. ; Michopoulos, A. ; Papakonstantinou, E. ; Yovos, J. G.
• Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
  Yamamoto, Shun ; Nagashima, Kengo ; Kawakami, Takeshi ; Mitani, Seiichiro ; Komoda, Masato ; Tsuji, Yasushi ; Izawa, Naoki ; Kawakami, Kentaro ; Yamamoto, Yoshiyuki ; Makiyama, Akitaka ; Yamazaki, Kentaro ; Masuishi, Toshiki ; Esaki, Taito ; Nakajima, Takako Eguchi ; Okuda, Hiroyuki ; Moriwaki, Toshikazu ; Boku, Narikazu
• Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study
  Zhang, Yongchang ; Zhang, Xiangyu ; Zhang, Ruiguang ; Xu, Qinqin ; Yang, Haiyan ; Lizaso, Analyn ; Xu, Chunwei ; Liu, Jun ; Wang, Wenxian ; Ou, Sai-Hong Ignatius ; Zhang, Jiexia ; Song, Zhengbo ; Yang, Nong
• Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer
  Chen, Jiayuan ; Hua, Qingling ; Wang, Haihong ; Zhang, Dejun ; Zhao, Lei ; Yu, Dandan ; Pi, Guoliang ; Zhang, Tao ; Lin, Zhenyu
• Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data
  Peterson, Rosemary G. ; Xiao, Rui ; Katcoff, Hannah ; Fisher, Brian T. ; Weiss, Pamela F.
• Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting
  Wang, Qianqian ; Gao, Wen ; Gao, Fangyan ; Jin, Shidai ; Qu, Tianyu ; Lin, Fan ; Zhang, Chen ; Zhang, Jingya ; Zhang, Zhihong ; Chen, Liang ; Guo, Renhua
• Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom
  Lester, Jason ; Escriu, Carles ; Khan, Sarah ; Hudson, Emma ; Mansy, Talal ; Conn, Andrew ; Chan, Samuel ; Powell, Ceri ; Brock, Juliet ; Conibear, John ; Nelless, Lauren ; Nayar, Vaneet ; Zhuo, Xiaohui ; Durand, Adeline ; Amin, Amerah ; Martin, Peter ; Zhang, Xinke ; Pawar, Vivek
• Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials
  Huang, Le-Tian ; Cao, Rui ; Wang, Yan-Ru ; Sun, Li ; Zhang, Xiang-Yan ; Guo, Yi-Jia ; Zhao, Jian-Zhu ; Zhang, Shu-Ling ; Jing, Wei ; Song, Jun ; Han, Cheng-Bo ; Ma, Jietao
• Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART
  Kanters, Steve ; Karim, Mohammad Ehsanul ; Thorlund, Kristian ; Anis, Aslam H. ; Zoratti, Michael ; Bansback, Nick
• Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
  Hosoya, Kazutaka ; Fujimoto, Daichi ; Morimoto, Takeshi ; Kumagai, Toru ; Tamiya, Akihiro ; Taniguchi, Yoshihiko ; Yokoyama, Toshihide ; Ishida, Tadashi ; Matsumoto, Hirotaka ; Hirano, Katsuya ; Kominami, Ryota ; Tomii, Keisuke ; Suzuki, Hidekazu ; Hirashima, Tomonori ; Tanaka, Satoshi ; Uchida, Junji ; Morita, Mitsunori ; Kanazu, Masaki ; Mori, Masahide ; Nagata, Kenji ; Fukuda, Ikue ; Tamiya, Motohiro
• Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
  DeMichele, Angela ; Cristofanilli, Massimo ; Brufsky, Adam ; Liu, Xianchen ; Mardekian, Jack ; McRoy, Lynn ; Layman, Rachel M. ; Emir, Birol ; Torres, Mylin A. ; Rugo, Hope S. ; Finn, Richard S.
• Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load
  Kibalama Ssemambo, Phionah ; Nalubega-Mboowa, Mary Gorrethy ; Owora, Arthur ; Serunjogi, Robert ; Kironde, Susan ; Nakabuye, Sarah ; Ssozi, Francis ; Nannyonga, Maria ; Musoke, Philippa ; Barlow-Mosha, Linda
• A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027
  Minegishi, Yuji ; Yamaguchi, Ou ; Sugawara, Shunichi ; Kuyama, Shoichi ; Watanabe, Satoshi ; Usui, Kazuhiro ; Mori, Masahide ; Hataji, Osamu ; Nukiwa, Toshihiro ; Morita, Satoshi ; Kobayashi, Kunihiko ; Gemma, Akihiko
• First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
  Köhne, Claus-Henning ; Hofheinz, Ralf-Dieter ; Mineur, Laurent ; Letocha, Henry ; Greil, Richard ; Thaler, Josef ; Fernebro, Eva ; Gamelin, Erick ; DeCosta, Lucy ; Karthaus, Meinolf
• Reise des S‑ICD zur First-Line-Therapie
  Kaya, Elif ; Wakili Noduschan, Reza ; Rassaf, Tienush
• Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status
  He, Xuejun ; You, Jijun ; Ding, Haibing ; Zhang, Zhisheng ; Cui, Lin ; Shen, Xiaomei ; Bian, Xiaoxia ; Liu, Yanqing ; Chen, Jue